US Stocks
/
Lexeo Therapeutics, Inc. Share Price
Lexeo Therapeutics, Inc. Share Price

Lexeo Therapeutics, Inc. Share Price

NASDAQ: LXEO | Micro Cap
$3.21
+$0.02 (0.47%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Lexeo Therapeutics, Inc. Stock Performance

Open
$3.34
Prev. Close
$3.19
Circuit Range
N/A
Day Range
$3.14 - $3.34
Year Range
$2.98 - $10.97
Volume
49,610
Average Traded
$3.21

Lexeo Therapeutics, Inc. Share Price Today

As of 10 October 2026, Lexeo Therapeutics, Inc.'s share price is $3.21. The stock opened at $3.34, compared to its previous close of $3.19. During today's trading session, Lexeo Therapeutics, Inc.'s share price traded between $3.14 and $3.34, with an average price of $3.24. Over the past 52 weeks, the stock has recorded a high of $10.97 and a low of $2.98. In terms of performance, Lexeo Therapeutics, Inc.'s share price has declined by 43.68% over the last six months and is down 67.96% on a year-on-year basis.

Lexeo Therapeutics, Inc. Share Price Chart

$3.14$3.34
L
Show Current Price
H

Lexeo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$172.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-37.12%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-27.56%

Lexeo Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$20.28-$20.92-$20.20-$25.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.16%3.44%-28.07%

Lexeo Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$66.39-$98.33-$99.96
Net Profit MarginN/AN/AN/A
Income ChangeN/A-48.11%-1.66%

About Lexeo Therapeutics, Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Lexeo Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.35
$3.23
-3.73%
Sep 2026
$4.71
$3.35
-32.63%
Aug 2026
$4.05
$4.98
+20.73%
Jul 2026
$4.71
$4.13
-11.39%
Jun 2026
$5.00
$4.66
-9.44%
May 2026
$5.63
$5.14
-9.82%
Apr 2026
$6.01
$5.70
-0.52%
Mar 2026
$6.75
$5.73
-20.19%
Feb 2026
$7.42
$7.18
-4.01%
Jan 2026
$9.85
$7.48
-24.60%
Dec 2025
$9.81
$9.92
+0.66%
Nov 2025
$9.37
$9.86
-1.65%

LXEO Share Price FAQs

What is Lexeo Therapeutics, Inc. share price today?

chevron-up
Lexeo Therapeutics, Inc. share price today is $3.21 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Lexeo Therapeutics, Inc. stock?

chevron-up
The 52 week high of Lexeo Therapeutics, Inc. stock is $10.97, while the 52 week low is $2.98 as of 10 Oct '26.

What is LXEO's market capitalisation today?

chevron-up
LXEO market capitalisation is $172.20M as of October 10, 2026, at 3:01 am IST.

What is LXEO's net income for the last quarter?

chevron-up
LXEO's net income for the last quarter is -25.87B USD.

What is the 5 year returns of LXEO?

chevron-up
The 5 year returns of LXEO is -74.76% as on 10 Oct '26.

What is the high & low stock price of LXEO today?

chevron-up
LXEO stock price hit a high of $3.34 and low of $3.14 as of 10 Oct '26.

Can I buy LXEO shares in India?

chevron-up
Yes. You can buy LXEO in India by opening an international trading account.